Advertisement

Vascular Closure Systems, Inc. Company Profile

00:03 EDT 23rd May 2013 | BioPortfolio

First in Human (FIH) Use of the FastSeal® Bioabsorbable Vascular Access Closure System – 100% Success Rate, Including Patients with Challenging Anatomy and Vessel Condition.


News Articles [ 765 Associated News Articles listed on BioPortfolio]

Vascular access and closure in coronary angiography and percutaneous intervention

The success of transcatheter therapeutics relies heavily on the choice of vascular access site and on adequate arteriotomy closure. In this article, Byrne and colleagues review the state-of-the-art an...

FDA approves Cardiva Medical's VASCADE Vascular Closure System

Cardiva Medical, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the VASCADE Vascular Closure System (VCS).

Vascular Closure Device Preserves the Femoral Artery

An innovative extravascular device facilitates entry site closure in patients undergoing percutaneous procedures through the femoral artery.

Vascular Closure Systems, Inc. Announces 30-Day Follow-Up Results for Phase I of the First in Human (FIH) Clinical Use, of the FastSeal® Bioabsorbable Vascular Access Closure System

Vascular Closure Systems, Inc.: 30-Day Follow-Up Results of the First in Human (FIH) Clinical Test Series of the FastSeal® Bioabsorbable Vascular Access Closure System â...

Four live cases using Toshiba's Infinix-i vascular X-ray systems to be showcased at NCVH

Enabling physicians to transition between cardiac and peripheral work seamlessly during a single procedure, Toshiba America Medical Systems, Inc.'s Infinix-i vascular X-ray systems facilitate better p...

Cardiva gains FDA approval for vascular closure device

Cardiva Medical has received premarket approval from the FDA for Vascade, an extravascular closure system used during percuta -More- Exporting to Europe: Medical Device Requirements Join BSI...

Vascular access device firm [Arstasis] brings in $51.2mm through its Series F venture round

Cardiovascular device firm [Arstasis Inc.] has raised $51.2mm through its Series F venture round. There were 14 undisclosed investors. The company is developing vascular access devices for arterial cl...

Vascular Closure Systems, Inc. Announces the Successful Completion of the First in Human (FIH) Clinical Trial of the 6 Fr. / 7 Fr. FastSeal® Bioabsorbable Vascular Access Closure System

Vascular Closure Systems, Inc.: The Company is pleased to announce the successful conclusion of Phase I and Phase II of the First in Human (FIH) clinical trial for our 6...

PubMed Articles [ 1115 Associated PubMed Articles listed on BioPortfolio]

Retrospective Evaluation of Safety and Effectiveness of the EXOSEAL Vascular Closure Device for Single Vascular Closure and Closure after Repeat Puncture in Diagnostic and Interventional Radiology: Single-center Experience.

To retrospectively evaluate the safety and effectiveness of the EXOSEAL vascular closure device (VCD) for first or repeated closure after retrograde percutaneous femoral arterial access.

Suitability of Exoseal Vascular Closure Device for Antegrade Femoral Artery Puncture Site Closure.

PURPOSE: To assess the efficacy and safety of the Exoseal vascular closure device for antegrade puncture of the femoral artery. METHODS: In a prospective study from February 2011 to January 2012, a to...

CIRSE Vascular Closure Device Registry.

PURPOSE: Vascular closure devices are routinely used after many vascular interventional radiology procedures. However, there have been no major multicenter studies to assess the safety and effectivene...

Comparison of two classification systems for vesicovaginal fistula.

INTRODUCTION AND HYPOTHESIS: This study aims to compare the prognostic value of two obstetric fistula classification systems. METHODS:...

The angio-seal evolution registry: outcomes of a novel automated angio-seal vascular closure device.

OBJECTIVES: The objective of the study was to assess the efficacy and safety of a novel vascular closure device, the Angio-Seal Evolution (EVCD), in patients undergoing routine cardiac catheterization...

Clinical Trials [ 1350 Associated Clinical Trials listed on BioPortfolio]

Patient Comfort With Vascular Closure

The purpose of this research study is to collect information on the amount of discomfort patients experience with one of two different vascular blood vessel closure devices, the MynxM5 Vas...

Plug Arterial Closure System (PACS, 7F)

The purpose of this study is to assess the safety and feasibility of the 7F Ensure Medical Vascular Closure Devices to facilitate hemostasis in patients undergoing diagnostic or interventi...

Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device

The purpose of this study is to determine whether the Ensure Medical Vascular Closure Device is more effective than standard manual compression at sealing the puncture made in the femoral...

Closure Method Study Following Tonsillectomy in Children

This is a children's study evaluating the effects of a tonsillectomy with tonsillar fossae closure compared to without closure of the operative wound.

Study of DERMABOND ProPen in Closure of Colectomy Wounds

2-octylcyanoacrylate (2-OCA) has been used extensively in clinical practice in trauma, plastic surgery, orthopaedic surgery, emergency medicine and paediatrics. Most studies on 2-OCA to da...

Companies [ 1392 Associated Companies listed on BioPortfolio]

Vascular Closure Systems, Inc.

First in Human (FIH) Use of the FastSeal® Bioabsorbable Vascular Access Closure System – 100% Success Rate, Including Patients with Challenging Anatomy and Vessel Conditio...

AccessClosure, Inc.

There are two methods of closing the femoral artery after cardiovascular procedures - manual compression and vascular closure devices. Manual compression entails up to 30 minutes of firm manual pressu...

InSeal Medical Ltd.

InSeal Medical Ltd. (Caesarea, Israel http://www.InSealMedical.com/) develops and manufactures percutaneous vascular closure devices for sealing of puncture site following a treat...

Closure Systems International, Inc.

Closure Medical Corporation

From its roots back in the 1970s as a small medical spin-off to today, Closure Medical Corporation has never lost sight of its commitment to revolutionize healing. Closure Medical seeks to fulfill the...

More Information about "Vascular Closure Systems, Inc." on BioPortfolio

We have published hundreds of Vascular Closure Systems, Inc. news stories on BioPortfolio along with dozens of Vascular Closure Systems, Inc. Clinical Trials and PubMed Articles about Vascular Closure Systems, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vascular Closure Systems, Inc. Companies in our database. You can also find out about relevant Vascular Closure Systems, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement